IMR Press / FBL / Volume 13 / Issue 9 / DOI: 10.2741/2944

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Macrophages and cancer
Show Less
1 SIgN Laboratory of Tumor Immunology, BMSI, A-STAR, Singapore 138665

*Author to whom correspondence should be addressed.

Academic Editor: Garnet Suck

Front. Biosci. (Landmark Ed) 2008, 13(9), 3494–3505; https://doi.org/10.2741/2944
Published: 1 May 2008
(This article belongs to the Special Issue Cellular therapy and vaccine development)
Abstract

Macrophages are ubiquitous cells physiologically involved in a variety of processes including pathogen destruction, inflammation, tissue repair and remodeling. They have a highly plastic phenotype and their functional polarization is determined by cytokines and factors found within local microenvironments. The role of macrophages during tumor development is ambiguous. At late stages, tumor-associated macrophages are known to produce molecules directly promoting tumor growth, invasion, and metastasis; the so called "myeloid-derived suppressor cells" also suppress the adaptive anti-tumor immune response. However, if properly activated, macrophages may control initial tumor development, and pilot studies in cancer patients suggest that adoptive transfers could be beneficial as adjuvant treatment in patients with minimal residual disease. Indeed, a limited tumor mass will probably be insufficient to educate macrophages into a suppressive phenotype. Thus, the macrophage effect in vivo may be determined by a variety of factors including the tumor type and stage, the degree of macrophage infiltration and their functional polarization. Unfortunately, the in vivo mechanisms responsible for the anti-tumor activity of macrophages are still unclear. Current promising strategies to target tumor macrophages in vivo include pharmacological agents capable to re-polarize them towards a classically activated phenotype or to inhibit their suppressive properties.

Share
Back to top